Convergent mechanisms of microglia-mediated synaptic dysfunction contribute to diverse neuropathological conditions

Nicole Scott-Hewitt1,2, Youtong Huang1,2, Beth Stevens1,2,3

  • 1F.M. Kirby Center for Neurobiology, Boston Children's Hospital, Boston, Massachusetts, USA.

Insights

Microglia, the brain's immune cells, are implicated in early synaptic dysfunction across many neurological diseases. Genetic and environmental factors drive these microglial changes, highlighting them as key therapeutic targets.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Synaptic dysfunction is an early indicator of neuropathological conditions, often preceding clinical symptoms.
  • Microglia are increasingly implicated in synaptic alterations due to genetic, transcriptional, and epidemiological evidence.
  • Environmental exposures, such as infection, can modulate neuroimmune interactions and contribute to synaptic changes.

Purpose of the Study:

  • To review evidence on the functional roles of microglia in various neuropathological contexts.
  • To discuss convergent mechanisms of microglial-mediated synaptic dysfunction.
  • To highlight microglia as potential therapeutic targets for neurological diseases.

Main Methods:

  • Review of existing genetic, transcriptional, and epidemiological studies.
  • Analysis of research on microglial function in neurodegeneration, aging, neuropsychiatric disorders, neurodevelopmental disorders, and infections.
  • Synthesis of findings to identify common mechanisms of microglial involvement in synaptopathies.

Main Results:

  • Convergent mechanisms underlie microglial-mediated synaptic dysfunction across diverse neurological conditions.
  • Early microglial changes, influenced by genetics and environment, are proposed as a common factor in synaptic pathologies.
  • Microglia play a crucial role in both the response to and contribution to synaptopathies.

Conclusions:

  • Microglia are central players in early synaptic pathology across a spectrum of neurological disorders.
  • Understanding microglial responses to genetic and environmental factors is crucial for addressing neurological diseases.
  • Microglia represent a promising and broadly relevant therapeutic target for neurological conditions.

Related Concept Videos

Long-term Depression01:03

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
2.6K
Excitatory and Inhibitory Effects of Neurotransmitters01:29

Excitatory and Inhibitory Effects of Neurotransmitters

When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of...
10.1K
Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
8.9K